^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IMMU-140

    i

    Associations

    News
    Trials
    Company:
    Gilead
    Drug class:
    Topoisomerase I inhibitor, HLA-DR-targeted antibody-drug conjugate
    Related drugs:

    Associations

    News
    Trials